Red blood cell production pathway

The "Red blood cell production pathway," also known as erythropoiesis, is a complex biological process responsible for generating mature red blood cells from hematopoietic stem cells. This multi-step process is tightly regulated by numerous hormones (notably erythropoietin), transcription factors such as GATA1 and hypoxia-inducible factor 1-alpha (HIF‑1α), cytokines, growth factors including stem cell factor and interleukin‑3, vitamins B12 and folic acid, iron metabolism regulators like transferrin receptors 1/2, and various epigenetic mechanisms[1][2][3][6]. The main molecular driver of terminal red blood cell maturation is the interaction between erythropoietin and its receptor EPOR on progenitor cells. Disruption in any part of this network can lead to diseases such as anemia or bone marrow failure syndromes. While many drugs act on components of this system—such as recombinant human erythropoietin stimulating agents or HIF prolyl hydroxylase inhibitors—the "red blood cell production pathway" itself is not a single therapeutic target but rather an integrated physiological cascade involving multiple molecular targets[2][4].

Other names

Erythropoiesis pathwayErythroid differentiation pathwayRed cell formation pathway